March of 2011 marked an important day in the history of how we treat cancer. The reason for its importance? In March 2011, the FDA approved a little molecule called Ipilimumab, better known as Yervoy, for use as a first line therapy in metastatic melanoma patients. Now, the FDA approves... read more →